A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH )

Clinical trial NCT04998760 · UNKNOWN

Trial details

NCT number: NCT04998760
Sponsor: Qi Zhou
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer

Start date: 2021-08-03
Primary completion: 2024-01-09
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.